Mona Talaschian1, Mahsa Mohammad Amoli2, Samaneh Enayati2, Moloud Payab3, Shirin Hasani-Ranjbar3,4. 1. 1Department of Internal Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2. 2Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. 3. 3Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. 4. EMRI (Endocrinology and Metabolism Research Institute), 5th Floor, Shariati Hospital, North Kargar Ave., Tehran, 1411413137 Iran.
Abstract
BACKGROUND: Despite assessing the expression of CD11c gene in macrophages in adipose tissues and suggesting association between the gene expressions and predisposing to obesity, the relationship of the changes in CD11c gene and its variants with obesity has not been exclusively evaluated. The present study aimed to assess the relationship between rs2230424 gene polymorphism leading a single amino acid Arginine 48 to Tryptophan interchange in CD11c gene protein chain and obesity in a sample of Iranian population. METHODS: This case-control association study was performed on 247 subjects including obese individuals and a sex- and age-matched healthy non-obese individuals. After DNA extraction, the DNA sequence containing the relevant polymorphic site was amplified by polymerase chain reaction (PCR). Determining different genotypic patterns of the SNP was carried out by restriction fragment length polymorphism (RFLP) analysis. To final draft the suspected genotypes of the SNP, DNA sequencing was performed. RESULTS: The frequency of wild genotype (TT) of Trp48Arg polymorphism of the CD11c gene in obese and non-obese groups was 97.9% and 94.6% and the frequency of heterozygous genotype (TC) was 2.1% and 5.4%, respectively with no significant difference (p = 0.230,). None of the participants had mutant genotypic pattern of the polymorphism. There was no association of the genotypic pattern of Trp48Arg polymorphism with different underlying risk factors as well as mean laboratory parameters. CONCLUSION: The presence of Trp48Arg polymorphism of the CD11c gene is not associated with increased risk for obesity among Iranian population.
BACKGROUND: Despite assessing the expression of CD11c gene in macrophages in adipose tissues and suggesting association between the gene expressions and predisposing to obesity, the relationship of the changes in CD11c gene and its variants with obesity has not been exclusively evaluated. The present study aimed to assess the relationship between rs2230424 gene polymorphism leading a single amino acid Arginine 48 to Tryptophan interchange in CD11c gene protein chain and obesity in a sample of Iranian population. METHODS: This case-control association study was performed on 247 subjects including obese individuals and a sex- and age-matched healthy non-obese individuals. After DNA extraction, the DNA sequence containing the relevant polymorphic site was amplified by polymerase chain reaction (PCR). Determining different genotypic patterns of the SNP was carried out by restriction fragment length polymorphism (RFLP) analysis. To final draft the suspected genotypes of the SNP, DNA sequencing was performed. RESULTS: The frequency of wild genotype (TT) of Trp48Arg polymorphism of the CD11c gene in obese and non-obese groups was 97.9% and 94.6% and the frequency of heterozygous genotype (TC) was 2.1% and 5.4%, respectively with no significant difference (p = 0.230,). None of the participants had mutant genotypic pattern of the polymorphism. There was no association of the genotypic pattern of Trp48Arg polymorphism with different underlying risk factors as well as mean laboratory parameters. CONCLUSION: The presence of Trp48Arg polymorphism of the CD11c gene is not associated with increased risk for obesity among Iranian population.
Authors: G Caimi; M G Tozzi Ciancarelli; F Ferrara; M Montana; V Calandrino; B Canino; R Lo Presti Journal: Clin Hemorheol Microcirc Date: 2005 Impact factor: 2.375
Authors: Fotini Nicolaou; Jens M Teodoridis; Heiyoung Park; Alexander Georgakis; Omid C Farokhzad; Erwin P Böttinger; Nicolas Da Silva; Philippe Rousselot; Christine Chomienne; Katalin Ferenczi; M Amin Arnaout; C Simon Shelley Journal: Blood Date: 2003-02-06 Impact factor: 22.113
Authors: John M Wentworth; Gaetano Naselli; Wendy A Brown; Lisa Doyle; Belinda Phipson; Gordon K Smyth; Martin Wabitsch; Paul E O'Brien; Leonard C Harrison Journal: Diabetes Date: 2010-03-31 Impact factor: 9.461
Authors: M T Audrey Nguyen; Svetlana Favelyukis; Anh-Khoi Nguyen; Donna Reichart; Peter A Scott; Alan Jenn; Ru Liu-Bryan; Christopher K Glass; Jaap G Neels; Jerrold M Olefsky Journal: J Biol Chem Date: 2007-10-04 Impact factor: 5.157